Study of Maixuekang capsules in healthy volunteers
This trial studies how Maixuekang capsules are processed in the body of healthy adults. It looks at the drug's levels over time to make sure it works safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 45 years old
- You must be a healthy adult
- Men must weigh at least 110 lbs (50 kg) and women at least 99 lbs (45 kg), with a BMI between 19 and 26
- You must agree to use effective birth control during and for 6 months after the study, and not plan to become pregnant or father a child in that time
- You cannot have bleeding problems, allergies to leeches, or certain habits like smoking, heavy drinking, or using recreational drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests whether a new oral drug (JMKX003801) is safe in healthy volunteers. It helps find the right dose and checks for side effects.
This study tests a new injection called LX22001 in healthy volunteers to see how it is processed in the body and if it is safe. It is a first-in-human trial, so you must be in good health and meet specific age, weight, and lifestyle requirements.
This study tests a new experimental medication (QX-4533) in healthy volunteers to find the best dose and see how it works in the body. It involves taking the medication and having your health monitored closely over time.
This study tests a new capsule called VV913 in healthy male volunteers to see how safe it is and how the body processes it. It is a first-in-human trial in China to gather basic safety information.
This trial studies a new drug called XKH001 in healthy volunteers. It is a single-dose study to see how the drug is processed by the body and to check for safety and tolerability.
This early-phase trial tests VV913 capsules in healthy men to see how safe they are and how the body processes the drug. It may help find the right dose for future studies.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.